Leu, M.; Mahler, H.; Reinecke, J.; König, U.M.; Dröge, L.H.; Guhlich, M.; Steuber, B.; Grade, M.; Ghadimi, M.; Ellenrieder, V.;
et al. FLOT Versus CROSS—What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction? Cancers 2025, 17, 2587.
https://doi.org/10.3390/cancers17152587
AMA Style
Leu M, Mahler H, Reinecke J, König UM, Dröge LH, Guhlich M, Steuber B, Grade M, Ghadimi M, Ellenrieder V,
et al. FLOT Versus CROSS—What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction? Cancers. 2025; 17(15):2587.
https://doi.org/10.3390/cancers17152587
Chicago/Turabian Style
Leu, Martin, Hannes Mahler, Johanna Reinecke, Ute Margarethe König, Leif Hendrik Dröge, Manuel Guhlich, Benjamin Steuber, Marian Grade, Michael Ghadimi, Volker Ellenrieder,
and et al. 2025. "FLOT Versus CROSS—What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction?" Cancers 17, no. 15: 2587.
https://doi.org/10.3390/cancers17152587
APA Style
Leu, M., Mahler, H., Reinecke, J., König, U. M., Dröge, L. H., Guhlich, M., Steuber, B., Grade, M., Ghadimi, M., Ellenrieder, V., Rieken, S., & König, A. O.
(2025). FLOT Versus CROSS—What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction? Cancers, 17(15), 2587.
https://doi.org/10.3390/cancers17152587
